# Genomic insights into antibiotic resistance, virulence traits and phylogenetic lineages of 141 clinical Helicobacter pylori isolates from Eastern China

**Authors:** Pingping Wang, Jing Zhao, Bin Lv, Xiaohan Zhang, Ming Li, Shenglan Chen, Bingjie Fan, Wenhong Wang

PMC · DOI: 10.3389/fcimb.2025.1726881 · Frontiers in Cellular and Infection Microbiology · 2026-01-05

## TL;DR

This study analyzed 141 H. pylori isolates from Eastern China to understand their antibiotic resistance, virulence traits, and genetic lineages.

## Contribution

The study provides genomic insights into resistance markers and virulence genotypes specific to H. pylori in Eastern China.

## Key findings

- High resistance to metronidazole, levofloxacin, and clarithromycin was observed in H. pylori isolates.
- Dominant virulence genotypes included cagA ABD and vacA s1-type in most isolates.
- Most strains belonged to the hpEastAsia lineage, with a few in hpEurope and hpAsia2.

## Abstract

To characterize antibiotic resistance, virulence genotypes and phylogenetic lineages of Helicobacter pylori (H. pylori) isolates from Eastern China and identify resistance/virulence-associated genetic variants.

Whole-genome sequencing (WGS) and phenotypic antimicrobial susceptibility testing (AST) for 6 antibiotics were performed on 141 H. pylori isolates from Hangzhou, China. Genetic analysis (resistance mutations, virulence genotyping, phylogenetic tree) and the assessment of antibiotic resistance related phenotype-genotype concordance were conducted.

Metronidazole resistance was highest (85.1%), followed by levofloxacin (57.4%), clarithromycin (53.9%) and amoxicillin (21.3%); tetracycline and furazolidone resistance was low at 2.8% and 0.7%, respectively. Key resistance mutations included 23S rRNA A2143G (clarithromycin, 92.91% phenotype-genotype concordance), gyrA N87K (levofloxacin, 89.13% concordance) and pbp1A 1785_1786insAGC (amoxicillin, 83.69% concordance). Dominant virulence genotypes: cagA ABD (86.26%), vacA s1-type (100%, 58.02% s1m2, 41.22% s1m1), htrA 171S (61.07%). 95.4% of strains clustered in hpEastAsia lineage; 3.8% in hpEurope, 0.76% in hpAsia2.

H. pylori isolate in Eastern China show high resistance to common antibiotics and dominant high-virulence genotypes. WGS identifies key resistance markers, aiding targeted H. pylori treatment.

## Linked entities

- **Genes:** 23S rRNA (23S ribosomal RNA) [NCBI Gene 2597968], GYRA (DNA GYRASE A) [NCBI Gene 820238], pbp1A (multimodular transpeptidase-transglycosylase PBP 1A) [NCBI Gene 7331562], S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279], vacA (prohibitin domain-containing protein) [NCBI Gene 8627181], HTRA1 (HtrA serine peptidase 1) [NCBI Gene 5654]
- **Chemicals:** metronidazole (PubChem CID 4173), levofloxacin (PubChem CID 149096), clarithromycin (PubChem CID 84029), amoxicillin (PubChem CID 33613), tetracycline (PubChem CID 54675776), furazolidone (PubChem CID 5323714)
- **Species:** Helicobacter pylori (taxon 210)

## Full-text entities

- **Genes:** HTRA1 (HtrA serine peptidase 1) [NCBI Gene 5654] {aka ARMD7, CADASIL2, CARASIL, CARASIL2, HtrA, L56}, vacA [NCBI Gene 48201093], cagA [NCBI Gene 48200769]
- **Chemicals:** levofloxacin (MESH:D064704), furazolidone (MESH:D005664), tetracycline (MESH:D013752), clarithromycin (MESH:D017291), amoxicillin (MESH:D000658), Metronidazole (MESH:D008795)
- **Species:** Helicobacter pylori (species) [taxon 210]
- **Mutations:** 1785_1786insAGC, A2143G, N87K

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12812873/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12812873/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12812873/full.md

---
Source: https://tomesphere.com/paper/PMC12812873